Proceeds will be used to increase patient access to metal-free OSSIOfiber® surgical implants, which provide a strong fixation solution while leaving nothing permanent behind December 02, 2024 09:00 AM Eastern Standard Time WOBURN, Mass.–(BUSINESS WIRE)–OSSIO, Inc.,…
Transaction follows a period of rapid growth and scaling, where Empyrean has emerged as a leading provider of integrated risk and performance management solutions for financial institutions. Funding will enable Empyrean to accelerate its product…
Advanced membrane technology positions ZwitterCo to unlock the potential of unconventional water sources, tackling the interlinked challenges of decarbonization and water scarcity July 09, 2024 06:30 AM Pacific Daylight Time WOBURN, Mass.–(BUSINESS WIRE)–ZwitterCo, which is…
According to filings with the U.S. Securities and Exchange Commission, Alsym Energy is raising up to $78,351,405.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Michael Hannon played a…
According to filings with the U.S. Securities and Exchange Commission, Biofrontera is raising $8,000,000.00 in new funding. About Biofrontera: Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of…
According to filings with the U.S. Securities and Exchange Commission, Feon Energy is raising up to $8,074,996.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Wenxiao Huang played a…
According to filings with the U.S. Securities and Exchange Commission, Hopewell Therapeutics is raising $10,000,001.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Louis Brenner played a…
According to filings with the U.S. Securities and Exchange Commission, VEIR is raising $24,902,885.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Tim Heidel played a key role in…
According to filings with the U.S. Securities and Exchange Commission, Gradiant Corp is raising $300,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Anurag Bajpayee played a key role…
According to filings with the U.S. Securities and Exchange Commission, Alloplex Biotherapeutics is raising $25,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Francescopaolo Borriello played a key role in…